13F Filings History of SUPERSTRING CAPITAL MANAGEMENT LP
- Latest 13F filing
- Q2 2026 - 14 Aug 2026
- Latest reported 13F value
- $158,294,596
- Largest 13F holdings
-
COGT AXSM GMAB CLDX TRVI RVMD DFTX VIR IMVT URGN CLYM ANL
+8 more
SVRA MPLT ORIC UTHR PCVX ONC CABA ZLAB - Form 13F summary
-
- SUPERSTRING CAPITAL MANAGEMENT LP Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
- Form 13F is generally due within 45 days after each calendar quarter ends.
- SUPERSTRING CAPITAL MANAGEMENT LP reported 32 equity holdings with a total reported market value of $158,294,596 for Q2 2026. Top reported holdings included COGT, AXSM, GMAB, CLDX, and TRVI.
- Manager signature
- Mark Doherty - COO
- Manager location
- New York, NY
13F snapshot
Latest parsed holdings, value, and filing-period context.
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow SUPERSTRING CAPITAL MANAGEMENT LP with Pro and return when a new 13F portfolio filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
Holdings Value
Form 13F evidence
Quarterly portfolio filings
SEC-reported 13F quarters for this filer, ordered by the latest accepted filing.
Latest quarter
Q2 2026
Latest value
$158,294,596
Quarter delta
+$18,324,629
Accepted
14 Aug 2026, 07:07
Rows shown
1-11 of 11
| Quarter | Holdings | SEC-reported value | Bought | Sold | Net | Top Holdings | Form Type | Accepted by SEC |
|---|---|---|---|---|---|---|---|---|
| Q2 2026 | 32 | $158,294,596 | +$60,633,800 | -$76,281,707 | -$15,647,907 | COGT, AXSM, GMAB, CLDX, TRVI | 13F-HR | 14 Aug 2026, 07:07 |
| Q1 2026 | 35 | $139,969,967 | +$82,592,825 | -$127,961,753 | -$45,368,928 | SMMT, IMVT, COGT, SVRA, URGN | 13F-HR | 14 May 2026, 14:49 |
| Q4 2025 | 45 | $186,779,622 | +$104,263,670 | -$68,521,232 | +$35,742,438 | CDTX, TERN, URGN, COGT, DVAX | 13F-HR | 17 Feb 2026, 08:14 |
| Q3 2025 | 35 | $101,502,599 | +$50,887,420 | -$54,209,065 | -$3,321,645 | ZLAB, CDTX, TERN, ETNB, IMVT | 13F-HR | 14 Nov 2025, 12:17 |
| Q2 2025 | 35 | $80,267,465 | +$32,889,505 | -$47,049,026 | -$14,159,521 | COGT, VRNA, NBIX, TERN, RARE | 13F-HR | 14 Aug 2025, 13:24 |
| Q1 2025 | 33 | $83,836,798 | +$34,626,130 | -$56,920,210 | -$22,294,080 | ZLAB, BBIO, VRNA, LEGN, PFE | 13F-HR | 15 May 2025, 11:06 |
| Q4 2024 | 38 | $113,869,430 | +$49,578,667 | -$30,190,584 | +$19,388,083 | ORIC, TERN, ZLAB, NVCR, BBIO | 13F-HR | 14 Feb 2025, 13:50 |
| Q3 2024 | 27 | $111,833,624 | +$61,912,243 | -$32,185,849 | +$29,726,394 | ZLAB, CYTK, TERN, GPCR, ORIC | 13F-HR | 14 Nov 2024, 11:22 |
| Q2 2024 | 39 | $79,328,656 | +$39,983,860 | -$78,132,649 | -$38,148,789 | CYTK, LEGN, TERN, BBIO, ETNB | 13F-HR | 14 Aug 2024, 13:11 |
| Q1 2024 | 37 | $151,235,764 | +$67,531,502 | -$59,534,281 | +$7,997,221 | CYTK, NKTX, ETNB, BBIO, SVRA | 13F-HR | 15 May 2024, 11:41 |
| Q4 2023 | 30 | $140,103,375 | $0 | $0 | $0 | IMGN, CYTK, ETNB, IONS, IDYA | 13F-HR | 14 Feb 2024, 12:25 |